MannKind Corporation (MNKD) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and welcome to the Mankind Corporation Second Quarter 2026 Financial Results Earnings Call. As a reminder, this call is being recorded on August 5th, 2026 and will be available for replay on the Mankind Corporation website shortly after this call for approximately 90 days. This call will contain forward-looking statements. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from these expectations. For further information on the company's risk factors, please see the form 10Q for the period ended June 30th, 2026, the earnings release and the slides prepared for this presentation. Joining us today from Mankind, our Chief Executive Officer, Michael Castagna, and Chief Financial Officer, Chris Prentiss. I'd now like to turn the conference over to Mr. Castagna. Please go ahead, sir. Thank you, operator. Good afternoon, everyone. Thank you for joining us for our second quarter 2026 call. I'll start with some opening remarks, walk you through some business updates. Chris will talk about our financial results and I'll close by giving a few closing statements here, followed by Q&A. Let me start by saying how we transformed our company and our potential growth trajectory with the strategy we outlined back in Q1. We laid out three major catalysts this year, a Fresno Pediatrics approval, opening an indication opportunity we have not had access to, Furosix ReadyFlow, which we have a CVR around because of the meaningful contribution this will have to the important growth of this franchise, and finally, the Phase 1b readout and attentive DPI in patients with IPF and underlying lung disease. These three things contribute to a solid foundation as we close out 2026 and move into 2027. Beyond the cata...